13:04 EDT Hims & Hers to sell Zepbound through telehealth platform, Bloomberg reports
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Eli Lilly threatens Zepbound copycat makers after shortage, Bloomberg reports
- Why Big Brands Are Quietly Returning to X
- HP, Autodesk, Hims & Hers, Quantum, Prospect: Insider Moves Revealed!
- Where Will Hims & Hers Stock Be in Five Years? Here’s What This Top Investor Expects
- Hims & Hers Health (HIMS) Shares Spike with Compounded Drug Strategy for GLP-1s